Pharmacology-Guided venetoclax dose reduction with azacitidine in older or unfit acute myeloid leukemia: A North African experience from a Moroccan single-center cohort and exploratory hospital cost-effectiveness analysis

Journal of Oncology Pharmacy Practice · Published 2026-06-02 · DOI 10.1177/10781552261456738

Authors (6)

Baztami Youssef, Ilham Jebrane, Mohamed Amine Aznag, Rim Chakara, Siham Ahchouch, Abderrahim Raissi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Youssef, B., Jebrane, I., Aznag, M., et al. (2026). Pharmacology-Guided venetoclax dose reduction with azacitidine in older or unfit acute myeloid leukemia: A North African experience from a Moroccan single-center cohort and exploratory hospital cost-effectiveness analysis. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261456738

Related articles